Apoptosis of Podocyte and Role of TGF-beta1 LAP in Unilateral Ureteral Obstruction in Mice.
- Author:
Won Dong LEE
1
;
Mi Seon KANG
;
Sun Woo KANG
;
Yang Wook KIM
;
Yeong Hoon KIM
Author Information
1. Department of Internal Medicine, Good Gang-An Hospital, Korea.
- Publication Type:Original Article
- Keywords:
Apoptosis;
Podocyte;
Transforming growth factor beta 1;
Ureteral obstructi
- MeSH:
Animals;
Apoptosis;
Fibrosis;
Humans;
Kidney;
Ligation;
Male;
Mice;
Podocytes;
Transforming Growth Factor beta1;
Transforming Growth Factors;
Ureter;
Ureteral Obstruction
- From:Korean Journal of Nephrology
2008;27(3):290-298
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: It was well known that transforming growth factor (TGF)-beta1 plays a pivotal role in interstitial fibrosis and loss of podocyte. We explored the effects of exogenous administration of TGF-beta1 latency-associated peptide (LAP) in a model of renal fibrosis induced by unilateral ureteral obstruction (UUO) and examined whether TGF-beta1 LAP can inhibit apoptosis of podocyte. METHODS: Twenty four male BALB/c mice were unilaterally obstructed of proximal ureters by ligation. Half of the mice with operation and half of 8 control were administered recombinant human LAP intraperitoneally. One to three mice per group were euthanized on days 3, 7, 14, and 21 after operation for observation of renal fibrosis and apoptosis of podocyte. RESULTS: Interstitial fibrosis was less severe in LAP-treated group. Obstructed kidneys from LAP- untreated mice had more glomerular apoptotic podocytes (TUNEL assay) compared to LAP-treated mice at day 7, 14, and 21 after operation. CONCLUSION: Intraperitoneal administration of TGF-beta1 LAP prevents the loss of podocyte & renal damage partially up to day 14 after operation.
